On Monday, Wave Life Sciences Ltd. (NASDAQ: WVE) was 16.57% up from the session before settling in for the closing price of $5.13. A 52-week range for WVE has been $3.50 – $7.67.
Here's Your FREE Report on the #1 Small-Cap Uranium Stock of '24.
Small-cap Uranium stocks are booming in 2024! The company we're about to show you is the ONLY small-cap stock in the space that benefits from ALL aspects of the global Uranium industry with none of the risks of running a mine. Smart investors will not be hesitating on this one!
Get the FREE Report with all the details here.
Sponsored
Healthcare Sector giant saw their annual sales surged by 610.91% over the last five years. When this article was written, the company’s average yearly earnings per share was at -95.14%. With a float of $98.27 million, this company’s outstanding shares have now reached $119.16 million.
The firm has a total of 268 workers. Let’s measure their productivity. In terms of profitability, gross margin is 92.04%, operating margin of -75.74%, and the pretax margin is -67.11%.
Wave Life Sciences Ltd. (WVE) Breakdown of a Key Holders of the stock
Also, it is sometimes useful to examine the sentiment of large-scale investors toward Wave Life Sciences Ltd. stocks. The insider ownership of Wave Life Sciences Ltd. is 21.22%, while institutional ownership is 75.30%. The most recent insider transaction that took place on Aug 21 ’24, was worth 279,555. In this transaction President and CEO of this company sold 48,366 shares at a rate of $5.78, taking the stock ownership to the 359,059 shares. Before that another transaction happened on Aug 21 ’24, when Company’s Officer proposed sale 48,366 for $5.78, making the entire transaction worth $279,638.
Wave Life Sciences Ltd. (WVE) Recent Fiscal highlights
According to the Wall Street analysts, stocks earnings will be around -95.14% per share during the next fiscal year.
Wave Life Sciences Ltd. (NASDAQ: WVE) Trading Performance Indicators
You can see what Wave Life Sciences Ltd. (WVE) is doing with its current performance indicators. In the most recent quarter, the stock posted a quick ratio of 0.99. In addition, a publicly-traded company’s price to sales ratio for the trailing twelve months stands at 6.75.
For the trailing twelve months, Company’s Diluted EPS (Earnings per Share) is -0.58, a number that is poised to hit -0.28 in the next quarter and is forecasted to reach -1.04 in one year’s time.
Technical Analysis of Wave Life Sciences Ltd. (WVE)
Analysing the last 5-days average volume posted by the [Wave Life Sciences Ltd., WVE], we can find that recorded value of 0.69 million was lower than the volume posted last year of 0.82 million. As of the previous 9 days, the stock’s Stochastic %D was 39.10%. Additionally, its Average True Range was 0.36.
During the past 100 days, Wave Life Sciences Ltd.’s (WVE) raw stochastic average was set at 66.41%, which indicates a significant decrease from 84.68% during the past two weeks. Based on volatility metrics of the stock, it showed a historical volatility of 82.73% in the past 14 days, which was higher than the 68.74% volatility it showed in the past 100 days.
At the time of writing, stock’s 50-day Moving Average is $5.76, while its 200-day Moving Average is $5.43. Now, the first resistance to watch is $6.32. This is followed by the second major resistance level at $6.65. The third major resistance level sits at $7.16. If the price goes on to break the first support level at $5.48, it is likely to go to the next support level at $4.97. Now, if the price goes above the second support level, the third support stands at $4.64.
Wave Life Sciences Ltd. (NASDAQ: WVE) Key Stats
There are 122,475K outstanding shares of the company, which has a market capitalization of 745.95 million. As of now, sales total 113,310 K while income totals -57,510 K. Its latest quarter income was 19,690 K while its last quarter net income were -32,920 K.
